SFRP1 and nasopharyngeal carcinoma: However, some studies have demonstrated that, in nasopharyngeal carcinoma, patients with low expression of SFRP1 exhibited significantly worse OS, DFS rate, and distant metastasis-free survival compared to patients with high expression of SFRP1 (Rogler et al. 2015).